Genentech Files for DJ against Regeneron Pharmaceuticals and Sanofi-Aventis
December 28, 2011
Genentech filed an action for declaratory judgment against Regeneron Pharmaceuticals and Sanofi-Aventis over three patents related to chimeric vascular endothelial growth factor receptor proteins. 12/23, Southern District of New York, 7:2011cv09463.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
